Position in VTRS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$37,396,987
+$6,243,576 QoQ
Shares Held
2,354,974
+2.1% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#57
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $338,809,559 across 34 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
6,276,154 | $58,556,516 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,702,176 | $57,669,722 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
262,192 | $44,189,839 | |
| 4 | VTRS |
Viatris Inc
This page
|
2,354,974 | $37,396,987 | |
| 5 | ZTS |
Zoetis Inc.
|
440,465 | $31,651,814 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,598,174 | $25,618,729 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
934,265 | $22,992,261 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
35,362 | $19,160,192 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,396,987 | 2,354,974 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $31,153,411 | 2,305,952 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $27,495,650 | 2,208,486 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $22,012,739 | 2,223,509 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $16,703,681 | 1,870,513 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $16,781,583 | 1,926,703 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $22,341,002 | 1,794,458 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,058,426 | 1,813,818 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $18,274,054 | 1,719,102 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $21,650,825 | 1,813,302 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $17,395,330 | 1,606,217 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $17,434,875 | 1,768,243 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,350,852 | 1,137,360 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $25,435,943 | 2,644,069 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,406,603 | 665,463 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,843,091 | 568,438 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,203,746 | 401,504 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $7,987,410 | 734,137 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $16,794,342 | 1,241,267 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $16,243,509 | 1,198,783 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $15,291,157 | 1,070,060 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $11,917,890 | 853,106 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $9,022,953 | 481,481 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||